70
Participants
Start Date
January 31, 2009
Primary Completion Date
November 30, 2011
Study Completion Date
December 31, 2014
panitumumab
cisplatin
docetaxel
neoadjuvant therapy
therapeutic conventional surgery
radiation therapy
Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh
UPMC Cancer Centers, Pittsburgh
Hollings Cancer Center at Medical University of South Carolina, Charleston
Wayne Hospital, Greenville
Good Samaritan Hospital, Dayton
Charles F. Kettering Memorial Hospital, Kettering
William Beaumont Hospital - Royal Oak Campus, Royal Oak
Mayo Clinic Cancer Center, Rochester
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis
Legacy Emanuel Hospital and Health Center and Children's Hospital, Portland
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
University of Chicago Cancer Research Center, Chicago
Evanston Hospital, Evanston
Simmons Cooper Cancer Institute, Springfield
Central Baptist Hospital, Lexington
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon
Blumenthal Cancer Center at Carolinas Medical Center, Charlotte
Wake Forest University Comprehensive Cancer Center, Winston-Salem
Providence Cancer Center at Providence Portland Medical Center, Portland
Geisinger Cancer Institute at Geisinger Health, Danville
Collaborators (1)
National Cancer Institute (NCI)
NIH
Amgen
INDUSTRY
Alliance for Clinical Trials in Oncology
OTHER